eCONSENT and clinical trials

Clinical research is possible because patient volunteers give their consent to participate in trials. Informed consent is a key part of enrolling patients in a clinical trial whereby the potential participant receives all the information they need about their role in the clinical trial. It is a central part of ICH GCP that informed consent

Unlocking the potential of biosimilars with Cromos Pharma

Biosimilars have long been heralded as a way of unlocking the potential of biologics by reducing costs to healthcare systems and increasing access to life-changing treatments. The development of biosimilar markets has differed across the world with European and APAC regions leading the way in terms of uptake, while the US has been slower to

Cromos Pharma supporting lung cancer clinical trials

November is Lung Cancer Awareness Month. Lung cancer is the most common cause of cancer death worldwide making up almost 25% of all cancer deaths. Every year, more people die of lung cancer than of colon, breast, and prostate cancers combined. In recent years, clinical research has led to significant breakthroughs in the treatment of lung cancer, giving